Alexis Biotech Limited
Records under this name other than patents Alexis Biotech Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Alexis Biotech Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,268,219 | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means Lapsed on the fee record Ended Sep 11, 2015 · USPTO record | Lapsed on the fee record | Ended Sep 11, 2015 | USPTO record |
| US 7,264,965 | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means Lapsed on the fee record Ended Sep 4, 2015 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2015 | USPTO record |
| US 7,521,197 | Method for producing cytotoxic T-cells Lapsed on the fee record Ended Apr 21, 2013 · USPTO record | Lapsed on the fee record | Ended Apr 21, 2013 | USPTO record |